These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1302351)

  • 21. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients.
    Wallace MB; Warren SG; Bates MC; Robinson PA
    W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of plasma lipids and apolipoproteins in the assessment of risk of myocardial infarction in the most common types of primary hyperlipoproteinemias].
    Zeman M; Zák A; Vítková D; Dusek F
    Cas Lek Cesk; 1991 Nov; 130(20-21):601-5. PubMed ID: 1769056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Personal experience with lovastatin, a HMG-CoA reductase inhibitor (Mevacor, MSD) in the treatment of hypercholesterolemia].
    Vaverková H; Skottová N; Pudilová L; Horcicka V; Jezdinský J; Trtková M
    Vnitr Lek; 1991 May; 37(5):463-9. PubMed ID: 1842144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia].
    Tonstad S; Gørbitz C; Ose L; Malt UF
    Tidsskr Nor Laegeforen; 1994 Aug; 114(19):2262-4. PubMed ID: 7992293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E; Truffert J; De Gennes JL
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus.
    Tawata M; Miwa I; Tsuchiya K; Ozawa M; Shindo H; Wakasugi M; Onaya T
    Arzneimittelforschung; 1995 Jun; 45(6):704-8. PubMed ID: 7646575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. I. Effect on cholesterol, lipid and apoprotein levels].
    Sznajd J; Idzior-Waluś B; Zabiński J; Wybrańska I; Korzus G; Iwanejko J
    Przegl Lek; 1990; 47(10):706-10. PubMed ID: 2089449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia].
    Julius U; Hora C; Gross P; Fücker K; Bergmann S; Hanefeld M
    Fortschr Med; 1992 Dec; 110(35-36):669-72. PubMed ID: 1487226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term efficacy and tolerability of combination therapy with lovastatin and acipimox in Chinese patients with type 2 diabetes mellitus and mixed dyslipidemia.
    Ko GT; Mak TW; Yeung VT; Chan DC; Lam CW; Tsang LW; Chow CC; Cockram CS
    J Clin Pharmacol; 1998 Oct; 38(10):912-7. PubMed ID: 9807971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of "prudent" diet and clofibrate upon apolipoprotein B in hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP; Suermann I; Göhmann E
    Med Klin; 1979 Feb; 74(8):279-83. PubMed ID: 216895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease.
    Tilly-Kiesi M; Mattila SP; Tikkanen MJ
    Angiology; 1993 Feb; 44(2):129-37. PubMed ID: 8434806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy and safety of fenofibrate and lovastatin in patients with primary type IIa or IIb hyperlipidaemia.
    Gholami K; Tavakoli N; Maleki M; Shafiee A
    J Clin Pharm Ther; 1998 Jun; 23(3):213-21. PubMed ID: 9831973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Procetophen--an alternative in the treatment of hypercholsterinemia?].
    Mordasini R; Grandjean EM; Nobile PC; Paumgartner G; Riva G
    Schweiz Med Wochenschr; 1979 Aug; 109(31):1140-3. PubMed ID: 472702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.